Excessive levels of platelet-derived EVs have been implicated in many diseases and AEMD is developing a pipeline of indications for the device leveraging highly cost efficient steps.
Excessive levels of platelet-derived EVs have been implicated in many diseases and AEMD is developing a pipeline of indications for the device...
116 Views
AEMD also has started to evaluate the potential of using the Hemopurifier with a simplified delivery system that could make it easier for oncology patients to receive Hemopurifier treatment.
AEMD also has started to evaluate the potential of using the Hemopurifier with a simplified delivery system that could make it easier for oncology...
106 Views
Aethlon Medical Inc - Currently
Currently, Hemopurifier treatment requires a dialysis machine and nephrologists and dialysis nurses to supervise and administer the...
304 Views
Levels of certain harmful particles typically returned to pre-treatment levels 1-3 weeks after treatment ended
Levels of certain harmful particles typically returned to pre-treatment levels 1-3 weeks after treatment ended, suggesting a potential benefit to...
469 Views
Levels of certain harmful particles typically returned to pre-treatment levels 1-3 weeks after treatment ended
Levels of certain harmful particles typically returned to pre-treatment levels 1-3 weeks after treatment ended, suggesting a potential benefit to...
493 Views